Back to Search
Start Over
First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca
- Source :
- GlobeNewswire. October 23, 2020
- Publication Year :
- 2020
-
Abstract
- MARSEILLE, France, Oct 23, 2020 (GLOBE NEWSWIRE via COMTEX) -- Milestone payment further bolsters Innate's cash position INTERLINK-1 represents first Phase 3 study examining IO approach in R/M SCCHN patients [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.639148280